{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34183821",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "03",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41579-021-00598-5"
    ],
    "Journal": {
      "ISSN": "1740-1534",
      "JournalIssue": {
        "Volume": "19",
        "Issue": "9",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep"
        }
      },
      "Title": "Nature reviews. Microbiology",
      "ISOAbbreviation": "Nat Rev Microbiol"
    },
    "ArticleTitle": "The importance of molecular diagnostics for infectious diseases in low-resource settings.",
    "Pagination": {
      "StartPage": "547",
      "EndPage": "548",
      "MedlinePgn": "547-548"
    },
    "Abstract": {
      "AbstractText": [
        "In settings with limited resources and a wide range of possible etiologies, molecular technologies offer an effective solution for infectious disease diagnostics, because they are agile, fast and flexible. Health systems that routinely use molecular diagnostics will achieve economies of scale, maximize limited expertize and rapidly respond to new threats."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-1694-7587"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria. iruka.n.okeke@gmail.com."
          }
        ],
        "LastName": "Okeke",
        "ForeName": "Iruka N",
        "Initials": "IN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Nigeria Centre for Disease Control, Jabi, Abuja, Nigeria."
          }
        ],
        "LastName": "Ihekweazu",
        "ForeName": "Chikwe",
        "Initials": "C"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MR/L00464X/1",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Rev Microbiol",
    "NlmUniqueID": "101190261",
    "ISSNLinking": "1740-1526"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Communicable Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Developing Countries"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "economics",
        "methods"
      ],
      "DescriptorName": "Molecular Diagnostic Techniques"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}